OPXA Financial Facts
Operating loss: -2MGeneral and administrative: 512.73K
See Full Income Statement
Accrued expenses: 1.1M
Total current liabilities: 2.85M
See Full Balance Sheet
Opexa Therapeutics, Inc. (OPXA) Earnings
|
Expand Research on OPXA
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -4.6% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -0.3% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/14/16 | Q316 | -$0.28 | -$0.25 | -$0.03 | $726.3K | $720K | N/A | Details | |||
8/11/16 | Q216 | -$0.30 | -$0.23 | -$0.07 | N/A | $720K | N/A | Details | |||
5/12/16 | Q116 | -$0.31 | -$0.35 | +$0.04 | $726.3K | $400K | N/A | Details | |||
3/15/16 | Q415 | N/A | -$0.50 | N/A | N/A | $720K | N/A | N/A | N/A | ||
11/10/15 | Q315 | -$0.42 | N/A | N/A | $726K | $307K | N/A | Details | |||
8/12/15 | Q215 | -$0.07 | -$0.08 | +$0.01 | N/A | N/A | N/A | Details | |||
11/30/-1 | Q115 | N/A | -$0.15 | N/A | N/A | $310K | N/A | N/A | N/A | ||
8/14/14 | Q214 | -$0.15 | -$0.13 | -$0.02 | $307.7K | $330K | N/A | Details |